elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36891530-53AD6285-A082-4FFF-8507-545C4AA5AF56
Q36891530-53AD6285-A082-4FFF-8507-545C4AA5AF56
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36891530-53AD6285-A082-4FFF-8507-545C4AA5AF56
Advancing outcome measures for the new era of drug development in cystic fibrosis.
P2860
Q36891530-53AD6285-A082-4FFF-8507-545C4AA5AF56
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36891530-53AD6285-A082-4FFF-8507-545C4AA5AF56
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3724c819a78c34f6dd3bd27f96e90e1f9e2f1932
P2860
Biomarkers and surrogate endpoints